Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Tag: targeted therapy
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
The past two weeks have seen a flurry of U.S. Food and Drug Administration (FDA) approvals of new treatments...
The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last...
This week, the U.S. Food and Drug Administration (FDA) added two new treatments to the armamentarium for hematologic oncologists...